Antonella Licchetta

1.1k total citations
22 papers, 830 citations indexed

About

Antonella Licchetta is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonella Licchetta has authored 22 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonella Licchetta's work include Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Treatment and Pharmacology (4 papers). Antonella Licchetta is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Cancer Treatment and Pharmacology (4 papers). Antonella Licchetta collaborates with scholars based in Italy, United States and Brazil. Antonella Licchetta's co-authors include Antonio Gnoni, Oronzo Brunetti, Antonio Giovanni Solimando, Antonella Argentiero, Vito Longo, Pierpaolo Correale, Sabina Delcuratolo, Nicola Silvestris, Maria Rotundo and Pierosandro Tagliaferri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Antonella Licchetta

21 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonella Licchetta Italy 16 490 282 211 197 131 22 830
Shan-Shan Jiang China 15 382 0.8× 365 1.3× 306 1.5× 159 0.8× 82 0.6× 18 808
Qiu-Zhong Pan China 22 552 1.1× 505 1.8× 442 2.1× 203 1.0× 125 1.0× 26 1.1k
Carl C. Schimanski Germany 18 718 1.5× 348 1.2× 309 1.5× 139 0.7× 173 1.3× 28 1.1k
Akio Saiura Japan 12 409 0.8× 145 0.5× 258 1.2× 111 0.6× 125 1.0× 38 766
Chang-Long Chen China 14 357 0.7× 220 0.8× 206 1.0× 130 0.7× 106 0.8× 17 611
Prashanth Prithviraj Australia 13 405 0.8× 192 0.7× 319 1.5× 155 0.8× 193 1.5× 28 753
Ilaria Marech Italy 18 291 0.6× 427 1.5× 441 2.1× 94 0.5× 192 1.5× 39 932
Chunhui Zhang China 13 324 0.7× 184 0.7× 210 1.0× 151 0.8× 102 0.8× 31 650
Peter Gaßmann Germany 16 381 0.8× 109 0.4× 238 1.1× 119 0.6× 114 0.9× 23 858
Philipp Manegold United States 14 446 0.9× 156 0.6× 404 1.9× 147 0.7× 124 0.9× 23 919

Countries citing papers authored by Antonella Licchetta

Since Specialization
Citations

This map shows the geographic impact of Antonella Licchetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonella Licchetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonella Licchetta more than expected).

Fields of papers citing papers by Antonella Licchetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonella Licchetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonella Licchetta. The network helps show where Antonella Licchetta may publish in the future.

Co-authorship network of co-authors of Antonella Licchetta

This figure shows the co-authorship network connecting the top 25 collaborators of Antonella Licchetta. A scholar is included among the top collaborators of Antonella Licchetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonella Licchetta. Antonella Licchetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fedele, Palma, Matteo Landriscina, Antonio Cusmai, et al.. (2024). Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study. Cancers. 16(20). 3442–3442. 2 indexed citations
3.
Gnoni, Antonio, Oronzo Brunetti, Vito Longo, et al.. (2020). Immune system and bone microenvironment: rationale for targeted cancer therapies. Oncotarget. 11(4). 480–487. 43 indexed citations
4.
Brunetti, Oronzo, Antonio Gnoni, Antonella Licchetta, et al.. (2019). Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib. Medicina. 55(10). 707–707. 54 indexed citations
5.
Longo, Vito, Oronzo Brunetti, Antonio Gnoni, et al.. (2019). Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Medicina. 55(10). 698–698. 51 indexed citations
6.
Gnoni, Antonio, Antonella Licchetta, Riccardo Memeo, et al.. (2019). Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies. Medicina. 55(12). 754–754. 59 indexed citations
7.
Longo, Vito, Antonio Gnoni, Andrea Casadei‐Gardini, et al.. (2017). Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget. 8(20). 33897–33910. 43 indexed citations
8.
Gnoni, Antonio, Nicola Silvestris, Antonella Licchetta, et al.. (2015). Metronomic chemotherapy from rationale to clinical studies: A dream or reality?. Critical Reviews in Oncology/Hematology. 95(1). 46–61. 64 indexed citations
9.
Perri, Francesco, Giuseppina Della Vittoria Scarpati, Carmine D’Aniello, et al.. (2015). Epstein–Barr virus infection and nasopharyngeal carcinoma. Anti-Cancer Drugs. 26(10). 1017–1025. 16 indexed citations
10.
Gnoni, Antonio, Daniele Santini, Mario Scartozzi, et al.. (2015). Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?. Expert Opinion on Therapeutic Targets. 19(12). 1623–1635. 56 indexed citations
11.
Perri, Francesco, Salvatore Pisconti, Manuel Conson, et al.. (2015). Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen. OncoTargets and Therapy. 8. 1345–1345. 8 indexed citations
12.
Gnoni, Antonio, Antonella Licchetta, Aldo Scarpa, et al.. (2013). Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions. International Journal of Molecular Sciences. 14(10). 19731–19762. 50 indexed citations
13.
Leo, Silvana, Caterina Accettura, Antonio Gnoni, et al.. (2012). Systemic Treatment of Gastrointestinal Cancer in Elderly Patients. Journal of Gastrointestinal Cancer. 44(1). 22–32. 17 indexed citations
14.
Petrioli, Roberto, Antonella Licchetta, Giandomenico Roviello, et al.. (2012). CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab. Cancer Investigation. 30(1). 65–71. 27 indexed citations
15.
Correale, Pierpaolo, Cirino Botta, Antonella Licchetta, et al.. (2011). Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients. Cancer Biology & Therapy. 12(2). 112–118. 30 indexed citations
16.
17.
Correale, Pierpaolo, Maria Rotundo, Cirino Botta, et al.. (2011). Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma. Clinical Cancer Research. 18(3). 850–857. 69 indexed citations
18.
Correale, Pierpaolo, Maria Rotundo, Maria Teresa Del Vecchio, et al.. (2010). Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy. Journal of Immunotherapy. 33(4). 435–441. 173 indexed citations
19.
Licchetta, Antonella, Pierpaolo Correale, Cristina Migali, et al.. (2010). Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate. Journal of Chemotherapy. 22(3). 201–204. 23 indexed citations
20.
Correale, Pierpaolo, Cinzia Remondo, Salvatore Francesco Carbone, et al.. (2010). Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients. Cancer Biology & Therapy. 9(9). 685–693. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shan-Shan Jiang Breakdown of academic impact, for papers by Qiu-Zhong Pan Breakdown of academic impact, for papers by Carl C. Schimanski Breakdown of academic impact, for papers by Akio Saiura Breakdown of academic impact, for papers by Chang-Long Chen Breakdown of academic impact, for papers by Prashanth Prithviraj Breakdown of academic impact, for papers by Ilaria Marech Breakdown of academic impact, for papers by Chunhui Zhang Breakdown of academic impact, for papers by Peter Gaßmann Breakdown of academic impact, for papers by Philipp Manegold
Rankless by CCL
2026